DE602007008949D1 - Verfahren zur verabreichung einer antitumoralen verbindung - Google Patents

Verfahren zur verabreichung einer antitumoralen verbindung

Info

Publication number
DE602007008949D1
DE602007008949D1 DE602007008949T DE602007008949T DE602007008949D1 DE 602007008949 D1 DE602007008949 D1 DE 602007008949D1 DE 602007008949 T DE602007008949 T DE 602007008949T DE 602007008949 T DE602007008949 T DE 602007008949T DE 602007008949 D1 DE602007008949 D1 DE 602007008949D1
Authority
DE
Germany
Prior art keywords
antitumorous
administering
compound
antitumorous compound
administering antitumorous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008949T
Other languages
English (en)
Inventor
Bernard Laffranchi
Jurgen Moll
Fabrina Bologna
Silvia Comis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nerviano Medical Sciences SRL
Original Assignee
Nerviano Medical Sciences SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences SRL filed Critical Nerviano Medical Sciences SRL
Publication of DE602007008949D1 publication Critical patent/DE602007008949D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
DE602007008949T 2006-11-03 2007-10-25 Verfahren zur verabreichung einer antitumoralen verbindung Active DE602007008949D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06123440 2006-11-03
PCT/EP2007/061491 WO2008052931A1 (en) 2006-11-03 2007-10-25 A method of administering an antitumor compound

Publications (1)

Publication Number Publication Date
DE602007008949D1 true DE602007008949D1 (de) 2010-10-14

Family

ID=38702074

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008949T Active DE602007008949D1 (de) 2006-11-03 2007-10-25 Verfahren zur verabreichung einer antitumoralen verbindung

Country Status (16)

Country Link
US (1) US20100256160A1 (de)
EP (1) EP2117539B1 (de)
JP (1) JP5547487B2 (de)
CN (1) CN101588800B (de)
AR (1) AR063459A1 (de)
AT (1) ATE479432T1 (de)
AU (1) AU2007316217A1 (de)
BR (1) BRPI0717998A2 (de)
CA (1) CA2668363A1 (de)
CL (1) CL2007003172A1 (de)
DE (1) DE602007008949D1 (de)
EA (1) EA200970444A1 (de)
ES (1) ES2350803T3 (de)
MX (1) MX2009004607A (de)
TW (1) TW200827361A (de)
WO (1) WO2008052931A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102105148B (zh) 2008-07-24 2013-04-10 内尔维阿诺医学科学有限公司 包含aurora激酶抑制剂和抗肿瘤药的治疗组合
US20110117212A1 (en) * 2008-07-24 2011-05-19 Nerviano Medical Sciences S.R.L. Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agent
CN105037399B (zh) * 2014-04-17 2017-04-26 深圳永泽医药股份有限公司 一类Bcr‑Abl双倍体抑制剂及制备方法与用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE363910T1 (de) * 1999-11-15 2007-06-15 Pharma Mar Sa Behandlung von krebserkrankungen durch aplidin
KR20040088457A (ko) * 2001-09-21 2004-10-16 레디 유에스 테라퓨틱스 인코포레이티드 신규 트리아진 화합물 제조방법 및 조성물
US7141568B2 (en) * 2003-07-09 2006-11-28 Pfizer Italia S.R.L. Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
CA2554463C (en) * 2004-02-06 2013-06-11 Threshold Pharmaceuticals, Inc. Anti-cancer therapies
TW200808311A (en) * 2006-03-30 2008-02-16 Nerviano Medical Sciences Srl Use of a kinase inhibitor for the treatment of particular resistant tumors

Also Published As

Publication number Publication date
CN101588800A (zh) 2009-11-25
CL2007003172A1 (es) 2008-06-27
TW200827361A (en) 2008-07-01
US20100256160A1 (en) 2010-10-07
AU2007316217A1 (en) 2008-05-08
CA2668363A1 (en) 2008-05-08
EP2117539B1 (de) 2010-09-01
EA200970444A1 (ru) 2009-12-30
JP2010523470A (ja) 2010-07-15
ES2350803T3 (es) 2011-01-27
ATE479432T1 (de) 2010-09-15
MX2009004607A (es) 2009-05-22
AR063459A1 (es) 2009-01-28
EP2117539A1 (de) 2009-11-18
WO2008052931A1 (en) 2008-05-08
BRPI0717998A2 (pt) 2013-12-03
CN101588800B (zh) 2012-01-04
JP5547487B2 (ja) 2014-07-16

Similar Documents

Publication Publication Date Title
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
DE602007012785D1 (de) Verfahren zur Herstellung einer Photomaske
ATE459416T1 (de) Verfahren zur beseitigung von endokrin wirksamen verbindungen
DE602008006478D1 (de) Eindickungszusammensetzung und Verfahren zur Eindickung wässriger Systeme
ATE535568T1 (de) Verfahren zur herstellung von polyethylenzusammensetzungen
DE602007007400D1 (de) Verfahren zur Niveauregulierung
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
DE502007001325D1 (de) Verfahren zur Lenkungsregelung
ATE513547T1 (de) Neue verfahren
ATE523949T1 (de) Verfahren zur regelung von wechselrichtern
ATE403639T1 (de) Verfahren zur herstellung substituierter biphenyle
DE602006020089D1 (de) Verfahren zur CVI
DE502007002941D1 (de) Verfahren zur Datenübertragung
DE502005010287D1 (de) Verfahren zur hydrocyanierung
DE602007007464D1 (de) Verfahren zur wiederherstellung einer polyolefinmiethylen-copolymer-kompatibilisierung
GB0713471D0 (en) Verfahren zur ladendruckregelung einer brennkraftmaschine
DE112008004027A5 (de) Verfahren zur Minderung von Kollisionsrisiken
DE502006003217D1 (de) Verfahren zur herstellung ungesättigter organosiliciumverbindungen
ATE430716T1 (de) Verfahren zur reinigung einer wässrigen lösung
ATE539067T1 (de) Verfahren zur herstellung einer aminomethylthiazolverbindung
DE602008004919D1 (de) Eindickungsmischungszusammensetzung und Verfahren zur Eindickung wässriger Systeme
DE502007003740D1 (de) Verfahren zur herstellung einer rutschhemmenden beschichtung
ATE544755T1 (de) Verfahren zur herstellung einer 5-alkoxy-4- hydroxymethylpyrazolverbindung
DE602005022360D1 (de) Verfahren zur herstellung einer zusammensetzung